The cure of leukemia through the optimist's prism - CLL Support
The cure of leukemia through the optimist's prism
You need to be a member of this community to see this post.
Featured Content
Jump to replies26 Replies
You need to be a member of this community to see hidden responses.
Featured Content
Seeking support and information for Chronic Lymphocytic Leukaemia?
Featured by CLL Support
Not what you're looking for?
You may also like...
Optimal Treatment Combinations in the Management of CLL/SLL Jeff Sharman, MD Provided by Clinical Care Options, LLC
Optimal Treatment Combinations in the Management of CLL/SLL Jeff Sharman, MD
An installment...
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'
In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
From the New England Journal of Medicine 10th December 2023
"The CLL treatment landscape has...
Relapsed CLL: New Approaches Prolong Survival
Dr Furman says that genetically unstable CLL patients need a combination therapy approach to...
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...
Related Posts
- Ibrutinib combinations in CLL therapy: scientific rationale and clinical results
- Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus Venetoclax
- BTK Degrader Shows Potential for Treating Refractory CLL and SLL
- Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor. (BRUIN CLL-321 Phase III trial results reported at ASH2024)
Clemastine (Tavegyl), an over-the-counter drug, found to be effective at inducing LMP and cell death
